NCT06378047 2026-02-09
Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
Clinical Trials
48 trialsNCT03484299 2025-10-29
Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma
University of Louisville
Phase 1 Recruiting
NCT07191548 2025-10-10
LIVERMET-IRE
Angiodynamics, Inc.
Phase NA Not yet recruiting
NCT06205849 2025-07-25
Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer
University of California, San Diego
Phase 1 Recruiting
NCT04276857 2025-05-13
SMART
University of Saskatchewan
Phase NA Recruiting
NCT06677762 2024-11-07
Irreversible Electroporation Ablation Combined With Anti-PD(L)1 Therapy for Locally Advanced Pancreatic Cancer
Ruijin Hospital
Not yet recruiting
NCT06185556 2024-08-23
COLDFIRE-III
Amsterdam UMC, location VUmc
Phase 2/3 Recruiting
NCT06047015 2024-08-09
Irreversible Electroporation (NanoKnife ®) and Immunotherapy for the Treatment of Stage IV Colorectal Cancer
University of Saskatchewan
Phase 1/2 Not yet recruiting
NCT03630640 2024-07-31
NIVOLEP
Assistance Publique - Hôpitaux de Paris
Phase 2 Completed
NCT05609656 2024-06-03
ELI
Zealand University Hospital
Phase 2 Terminated
NCT05435053 2023-09-15
CHECKPOINT
Zealand University Hospital
Phase 2 Terminated
NCT01939665 2022-12-20
PANFIRE
Amsterdam UMC, location VUmc
Phase 1/2 Completed
NCT02082782 2022-12-20
COLDFIRE-2
Amsterdam UMC, location VUmc
Phase 2 Completed
NCT02791503 2022-12-20
CROSSFIRE
Amsterdam UMC, location VUmc
Phase NA Completed
NCT04612530 2022-12-20
PANFIRE-3 Trial: Assessing Safety and Efficacy of Irreversible Electroporation (IRE) + Nivolumab + CpG for Metastatic Pancreatic Cancer
Amsterdam UMC, location VUmc
Phase 1 Unknown
NCT03362749 2022-10-14
EAST
National Taiwan University Hospital
Unknown
NCT03257150 2022-08-11
A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer
University Health Network, Toronto
Phase NA Completed
NCT04717687 2022-07-13
HOPE
Poitiers University Hospital
Phase NA Withdrawn
NCT04835402 2022-03-09
EPIC-1
Aalborg University Hospital
Phase 2 Unknown
NCT02333773 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02425059 2021-09-05
Irreversible Electroporation(IRE) For Unresectable Rectal Neoplasms
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430636 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430662 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430701 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT03337997 2021-05-06
A Pilot Study of IRE for Resectable Pancreatic Cancer
University of Saskatchewan
Phase NA Withdrawn
NCT04093141 2021-04-01
CHEMOFIRE-2
Aalborg University Hospital
Phase NA Unknown
NCT04404647 2021-03-26
Irreversible Electroporation of Unresectable Liver Tumors
Aalborg University Hospital
Phase NA Withdrawn
NCT04816045 2021-03-25
Neoadjuvant Electrochemotherapy for Colorectal Cancer - a Randomized Controlled Trial
Zealand University Hospital
Phase 1/2 Unknown
NCT02981719 2021-01-22
Simultaneous Gemcitabine and Irreversible Electroporation for Locally Advanced Pancreatic Cancer
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT03040453 2020-11-30
IRAL
Karolinska Institutet
Phase NA Withdrawn
NCT03180437 2020-11-02
Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic Cancer
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT04139070 2020-08-20
Electrochemotherapy for Non-curable Gastric Cancer
Zealand University Hospital
Phase 1 Unknown
NCT03183219 2020-07-13
Safety and Efficiency of γδ T Cell Against Liver Cancer
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT02828865 2020-07-07
A Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers
National Taiwan University Hospital
Phase NA Completed
NCT02841436 2020-07-07
A Clinical Research About Using Irreversible Electroporation to Treat Locally Advanced Pancreatic Cancer
National Taiwan University Hospital
Phase NA Completed
NCT04310553 2020-03-17
An Open-label, Multicenter, Prospective Study of Irreversible Electroporation (Nano Knife) Combined With Radiotherapy and Chemotherapy in Patients With Locally Advanced Pancreatic Cancer
RenJi Hospital
Phase NA Unknown
NCT02926040 2020-02-27
IRE Qol
Insel Gruppe AG, University Hospital Bern
Terminated
NCT02952859 2020-02-26
IRE Marg
Insel Gruppe AG, University Hospital Bern
Terminated
NCT03069599 2020-02-26
IRE Immuno
Insel Gruppe AG, University Hospital Bern
Terminated
NCT02079623 2020-01-10
NanoKnife
Aalborg University Hospital
Completed
NCT02718859 2019-09-12
Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT03008343 2019-09-12
Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT02898649 2019-02-15
Safety and Efficacy of Irreversible Electroporation for Locally Advanced Pancreatic Cancer
Yonsei University
Phase NA Unknown
NCT03239184 2019-01-25
Bioinformation Therapy for Pancreatic Cancer
Fuda Cancer Hospital, Guangzhou
Phase 2/3 Completed
NCT03350477 2019-01-25
Bioinformation Therapy for Gastric Cancer
Fuda Cancer Hospital, Guangzhou
Phase 2/3 Completed
NCT02787954 2018-10-18
Liver
The University of Texas Health Science Center, Houston
Terminated
NCT02010801 2013-12-13
Evaluation of Tumor Ablation Effects by Irreversible Electroporation for Patients With Malignant Liver Tumors
National Taiwan University Hospital
Phase NA Completed
NCT01442324 2012-07-18
Pilot Study of Irreversible Electroporation (IRE) to Treat Metastatic Liver Cancer & Cholangiocarcinoma
Azienda Ospedaliera di Padova
Phase NA Unknown